It remains an experimental compound, and its full safety profile is still being established through ongoing Phase 2 and Phase 3 trials
(Main) 28411 Northwestern Highway Suite 300 Southfield, MI 48034 Phone: (248) 595-7544 19 Clifford St
While Semaglutide GLP-1 has proven successful, tirzepatide has shown even better results in clinical trials
(Commercial Product) Available Dosage Strengths 0.25 mg / dose | 0.5 mg / dose | 1 mg / dose | 1.7 mg / dose | 2.4 mg / dose Want to Prescribe
There may be something else that needs addressing
Real-world data with behavioural support Second Natures peer-reviewed research, published in JMIR Formative Research (2025), showed that semaglutide, combined with registered dietitian support and a structured behaviour change programme, produced an average 19.1% weight loss at 12 months, with 77.7% of participants achieving at least 10% weight loss